|http://ghr.nlm.nih.gov/ A service of the U.S. National Library of Medicine®|
The official name of this gene is “calcium channel, voltage-dependent, L type, alpha 1F subunit.”
CACNA1F is the gene's official symbol. The CACNA1F gene is also known by other names, listed below.
The CACNA1F gene belongs to a family of genes that provide instructions for making calcium channels. These channels, which transport positively charged calcium atoms (calcium ions) across cell membranes, play a key role in a cell's ability to generate and transmit electrical signals.
The CACNA1F gene provides instructions for making one part (the alpha-1 subunit) of a calcium channel called CaV1.4. This subunit forms the hole (pore) in the cell membrane through which calcium ions can flow. CaV1.4 channels are found in many types of cells, although they play a particularly important role in a specialized tissue at the back of the eye called the retina. Within the retina, the channels are located in light-detecting cells called photoreceptors. The retina contains two types of photoreceptors: rods and cones. Rods are responsible for vision in low light. Cones provide vision in bright light, including color vision.
CaV1.4 channels appear to play a critical role in normal vision. Studies suggest they help relay visual signals from rods and cones to other retinal cells called bipolar cells. This signaling is an essential step in the transmission of visual information from the eyes to the brain.
The CACNA1F gene belongs to a family of genes called CACN (calcium channels).
A gene family is a group of genes that share important characteristics. Classifying individual genes into families helps researchers describe how genes are related to each other. For more information, see What are gene families? (http://ghr.nlm.nih.gov/handbook/howgeneswork/genefamilies) in the Handbook.
More than 70 mutations in the CACNA1F gene have been identified in people with X-linked congenital stationary night blindness. Mutations in this gene are responsible for the incomplete form of the disorder, which is characterized by vision problems including a loss of sharpness (reduced acuity), nearsightedness (myopia), involuntary movements of the eyes (nystagmus), and eyes that do not look in the same direction (strabismus). Many affected individuals also have difficulty seeing in low light (night blindness).
CACNA1F mutations change the structure of the alpha-1 subunit, which alters or eliminates the function of CaV1.4 channels. These changes prevent the normal transport of calcium ions across the cell membrane of photoreceptor cells. A loss of calcium ion transport disrupts the ability of both rods and cones to transmit visual signals, which impairs vision.
Mutations in the CACNA1F gene cause several other rare disorders that impair vision. These include Åland Island eye disease, X-linked cone-rod dystrophy, an X-linked retinal disorder in New Zealand, and retinal and optic disc atrophy. Each of these disorders has been reported in only a few individuals or families worldwide. They cause vision problems similar to those of X-linked congenital stationary night blindness.
Researchers have identified at least one CACNA1F mutation that can cause Åland Island eye disease (also known as Forsius-Eriksson syndrome). This condition was first described in a family from the Åland Islands, which are in the Baltic Sea off the coast of Sweden. Åland Island eye disease is characterized by reduced visual acuity, nystagmus, an irregular curvature of the front part of the eye (astigmatism), myopia, abnormal color vision, and night blindness. The mutation associated with this disorder deletes a segment of genetic material from the CACNA1F gene, which significantly alters the structure of the alpha-1 subunit of CaV1.4 channels. These changes prevent the normal transport of calcium ions across the cell membrane of photoreceptor cells. A loss of calcium ion transport disrupts the ability of both rods and cones to transmit visual signals.
At least one other CACNA1F mutation is responsible for X-linked cone-rod dystrophy (also known as CORDX3). The signs and symptoms of this condition include reduced visual acuity, an increased sensitivity to light (photophobia), myopia, and impaired color vision. These vision problems tend to worsen over time. The mutation associated with this disorder deletes part of the alpha-1 subunit, which likely prevents the production of functional CaV1.4 channels. A loss of these channels keeps photoreceptor cells from relaying visual signals normally, which leads to impaired vision.
A CACNA1F mutation has also been found to cause an X-linked retinal disorder in a large Maori family from New Zealand. The major features of this disorder include reduced visual acuity, abnormal color vision, photophobia, and mild nystagmus. Some affected individuals have also had intellectual disability. The CACNA1F mutation associated with this condition alters a single protein building block (amino acid) in the alpha-1 subunit, which appears to overactivate CaV1.4 channels. The resulting increase in calcium ion transport probably disrupts the transmission of visual signals in the retina.
Another eye disorder, known as retinal and optic disc atrophy, has been associated with a CACNA1F mutation in two Japanese brothers. The affected individuals experienced a progressive decline in visual acuity and color vision. These vision problems were caused by deterioration of the retina, including an area called the optic disc (which is where the retina connects with the nerve that relays visual information to the brain). The CACNA1F mutation responsible for retinal and optic disc atrophy alters the structure of the alpha-1 subunit, which probably leads to the production of nonfunctional CaV1.4 channels. This mutation has also been identified in at least one Japanese family with X-linked congenital stationary night blindness. It is unclear why this single genetic change can cause different vision abnormalities in different families.
Cytogenetic Location: Xp11.23
Molecular Location on the X chromosome: base pairs 49,205,062 to 49,233,370
The CACNA1F gene is located on the short (p) arm of the X chromosome at position 11.23.
More precisely, the CACNA1F gene is located from base pair 49,205,062 to base pair 49,233,370 on the X chromosome.
See How do geneticists indicate the location of a gene? (http://ghr.nlm.nih.gov/handbook/howgeneswork/genelocation) in the Handbook.
You and your healthcare professional may find the following resources about CACNA1F helpful.
You may also be interested in these resources, which are designed for genetics professionals and researchers.
See How are genetic conditions and genes named? (http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/naming) in the Handbook.
amino acid ; astigmatism ; atrophy ; calcium ; cell ; cell membrane ; channel ; cones ; congenital ; disability ; gene ; involuntary ; ions ; ion transport ; mutation ; myopia ; nearsightedness ; nystagmus ; photophobia ; photoreceptor ; protein ; retina ; rods ; sensitivity ; strabismus ; subunit ; synapse ; syndrome ; tissue ; visual acuity ; voltage
You may find definitions for these and many other terms in the Genetics Home Reference Glossary (http://www.ghr.nlm.nih.gov/glossary).
The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.